Restoring Hearing Loss, CAR T Manufacturing, DNA-Based Medicines, Nvidia and Recursion; Eric Topol
Get every episode summarized
Each time Touching Base publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
Episode 6 (January 26, 2024): 11-year-old regains hearing after gene therapy; Kyverna uses blood draw instead of apheresis for CAR T manufacturing; DNA production technology with GSK and Elegen, StockWatch with Nvidia and Recursion; an interview with renowned cardiologist, Eric Topol, MD
Listed below are key references to the GEN stories, media and other items discussed in this episode of Touching Base:
Gene Therapy Restores Hearing in 11-Year-Old After Just One Month
GEN, January 24th, 2024
GSK and Elegen Team Up to Develop DNA-Based Medicines and Vaccines
By Jonathan Grinstein, GEN Edge, January 24th, 2024
Blood Brothers: Kyverna Reinvents Autologous CAR T Manufacturing from Blood Draw
By Jonathan Grinstein, GEN Edge, January 24th, 2024
StockWatch: Nvidia Jumps 24% on Recursion, Amgen AI Partnerships
By Alex Philippidis, GEN Edge, January 21st, 2024
Five Deaf Children Have Hearing Restored by AAV-Based Gene Therapy
GEN, January 25th, 2024
Hosted on Acast. See acast.com/privacy for more information.
Get every episode summarized
Each time Touching Base publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Touching Base
BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C...
Touching Base
Axiom’s Hong Kong Bet, Latigo’s Positive Phase II, and Base Editors for Huntingt...
Touching Base
Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics
Touching Base
Merck and Insilico Make Deals, Claude Science’s Debut, Vaccines for Neglected Di...
Touching Base